New Issue: BMO sells $382,000 bullish enhanced notes on iShares Biotechnology ETF

By Marisa Wong

Morgantown, W.Va., Sept. 11 – Bank of Montreal priced $382,000 of 0% bullish enhanced return notes due Oct. 5, 2018 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

The payout at maturity will be par plus 300% of any fund gain, up to a maximum redemption amount of $1,127.50 per $1,000 principal amount.

Investors will be exposed to any losses.

BMO Capital Markets Corp. is the agent.

Issuer:	Bank of Montreal
Issue:	Bullish enhanced return notes
Underlying fund:	iShares Nasdaq Biotechnology ETF
Amount:	$382,000
Maturity:	Oct. 5, 2018
Coupon:	0%
Price:	Par
Payout at maturity:	Par plus 300% of any fund gain, capped at 12.75%; exposure to any losses
Initial level:	$324.32
Pricing date:	Aug. 30
Settlement date:	Sept. 5
Agent:	BMO Capital Markets Corp.
Fees:	1.93%
Cusip:	06367TC57

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.